Novartis has signed an agreement for the acquisition of all the outstanding shares of US-based Avidity Biosciences.

The MHRA's raid follows an uptick in the trade of illegal GLP-1RA drugs used for obesity and type 2 diabetes amid shortages ...

Lilly and Inctye will be seeking a label update for the JAK inhibitor for its use in paediatric patients with alopecia areata ...

Dupixent’s Q3 sales increased by 26.2%, breaking through the €4bn ceiling for the first time in a single quarter.

GSK has received US Food and Drug Administration (FDA) approval for Blenrep to be used along with BVd for multiple myeloma.

Immunotherapy drugs continue to gain momentum across a growing range of disease areas with blockbusters such as Merck’s ...

Roche’s CEO Thomas Schinecker said the drugmaker is continuing talks with the US government over drug pricing reforms, as ...

A report by GlobalData revealed that the biotech industry witnessed a 70.9% increase in total venture financing deal value.

Merck KGaA could now have a head start in the race to market Precem-TcT, which could become the first widely approved ADC in ...

Remote monitoring technologies offer a vital option for people with diabetes to manage their conditions, with tech developed ...

Ipsen is set to purchase all issued and outstanding shares of the French biotech company ImCheck Therapeutics.

At AAO 2025, EyePoint Pharmaceuticals presented updates on its investigational therapy EYP-1901 (vorolanib) for DME and wAMD.